Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis

NCT01321476 is registered in ClinicalTrials.gov with Piedmont Healthcare as lead sponsor.

NCT NCT01321476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01321476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
Lead sponsor
Piedmont Healthcare
Phase
Observational
Overall status
Withdrawn
Start date
Not reported
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease